I 116th CONGRESS 1st Session H. R. 1344 IN THE HOUSE OF REPRESENTATIVES February 25, 2019 Mr. Doggett (for himself, Mr. Blumenauer , Mr. Cartwright , Ms. Judy Chu of California , Mr. Cummings , Ms. DeLauro , Mr. DeSaulnier , Mr. Grijalva , Ms. Hill of California , Ms. Kaptur , Mr. Khanna , Ms. Moore , Mrs. Napolitano , Ms. Ocasio-Cortez , Ms. Norton , Ms. Pingree , Mr. Pocan , Ms. Waters , Mr. Welch , and Mr. Langevin ) introduced the following bill; which was referred to the Committee on Ways and Means , and in addition to the Committees on Energy and Commerce , and the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.